Skip to content

Testing values clarification methods in cancer screening

Testing an explicit values clarification method developed via user-centred design for increasing values-congruent decisions

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12285243
Enrollment
1470
Registered
2026-06-19
Start date
2026-06-24
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Screening for breast or prostate cancer Cancer

Interventions

Qualtrics, an online survey platform that subcontracts with survey panels (e.g., survey panels like Ipsos, Leger), will be used to recruit participants . Participants will be found by stratified rando

Sponsors

Université Laval
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. Be able to participate in English or in French 2. Adults 50-59 years old in Canada in the eligible age range for cancer screening

Exclusion criteria

Exclusion criteria: 1. A personal history of breast or prostate cancer, with known genetic risk factors (e.g., BRCA1) 2. First-degree relatives with the relevant cancer, who have dense breasts or an enlarged prostate, or who have previously been screened for the relevant cancer.

Design outcomes

Primary

MeasureTime frame
Values congruence measured using the concordance between initial stated values and decision intention scores as follows: Values congruence = 10 - ¦decision intention - initial stated values¦ Values congruence will therefore be a continuous scale ranging from 0 = worst congruence, and 10 = best congruence. at immediately following the intervention

Countries

Canada

Contacts

Public ContactHolly Witteman
holly.witteman@fmed.ulaval.ca+1 418-656-2131

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026